Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$439,022,601
+$120,809,775 QoQ
Shares Held
366,026
+5.8% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#166
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Dec 31, 2025CallValue
$429,872
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $1,560,895,629 across 16 Drug Manufacturers - General names. LLY ranks #1 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
366,026 | $439,022,601 | |
| 2 | JNJ |
Johnson & Johnson
|
1,094,399 | $277,944,514 | |
| 3 | ABBV |
AbbVie Inc.
|
990,692 | $249,297,734 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,229,081 | $157,936,908 | |
| 5 | AMGN |
Amgen Inc
|
333,544 | $120,782,953 | |
| 6 | PFE |
Pfizer Inc
|
3,183,708 | $76,663,688 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
413,202 | $52,203,940 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
883,910 | $50,930,894 |
All Filings in LLY
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $439,022,601 | 366,026 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $318,212,826 | 345,970 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $354,409,078 | 329,781 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $429,872 | 400 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $48,800 | 400 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $237,264,769 | 310,963 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $197,875,115 | 253,839 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $203,410,896 | 246,287 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $179,565,656 | 232,598 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $200,924,104 | 226,792 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $203,639,880 | 224,922 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $7,650 | 1,000 | Put | Sole | 2024-05-24 | |
| 2024-03-31 | $175,289,169 | 225,319 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $42,553,160 | 73,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $38,565,396 | 71,799 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $31,764,015 | 67,730 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $21,589,098 | 62,865 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $22,832,074 | 62,410 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,500,307 | 44,844 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,240,606 | 53,174 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $13,619,184 | 47,558 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $12,863,841 | 46,571 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,402,086 | 49,349 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $12,617,632 | 54,974 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $8,822,014 | 47,222 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,052,654 | 47,694 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $1,106,597 | 7,476 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,125,946 | 6,858 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $978,114 | 7,051 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||